EUVIMED · CrossrefZeitschrift
Basal Ganglia
ISSN 2210-5336 · Elsevier BV
Neueste Artikel
Striatal dopamine neurotransmission: Regulation of release and uptake
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to l-Dopa phobia
The vulnerable ventral tegmental area in Parkinson’s disease
Extrastriatal plasticity in parkinsonism
GPR88: A putative signaling molecule predominantly expressed in the striatum: Cellular localization and developmental regulation
Cervical dystonia: A new phenomenological classification for botulinum toxin therapy
V34 Depression in Parkinson’s Disease and its contribution to care-dependency in outpatients
V35 The cost-effectiveness of deep brain stimulation for Parkinson’s disease
V36 Health-related quality of life in patients with Parkinson’s disease in Europe: Multicenter study of the EuroPA Study Group
V37 Common variants affect risk for the tauopathy progressive supranuclear palsy
V38 Generation of ferric iron links oxidative stress to α-synuclein oligomer formation
V39 Preserved serotonin transporter binding in de novo Parkinson’s disease: Negative correlation with the dopamine transporter
V89 Longitudinal findings of the Magnetic Resonance Imaging (MRI) scale in the NNIPPS Trial: Sensitivity to change over 3years follow-up in patients with Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA)
V90 Longitudinal description of Magnetic Resonance Imaging (MRI) findings in a large prospective cohort of patients with Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA)
V91 Conditioning of passive behaviours under levodopa treatment
V92 Acceleration of syllable repetition in Parkinson’s disease depends on the more affected side – Evidence for a differential role of the basal ganglia in motor speech performance?
V93 Reduced LRRK2-positive neurons in the striatum of Parkinson’s disease patients
V94 Voxel-based MRI volumetry of the caudate in Huntington’s disease, compared with manual volumetry
P95 Classical neurotransmitters and neuropeptides involved in Parkinson’s disease: An enlarged neuronal network
P96 Instability of syllable repetition in Parkinson’s disease – Differential effect of levodopa and deep brain stimulation (STN)
P97 Neurophysiological differentiation between essential and parkinsonian tremor
P98 Effect of micro lesions on repetitive ballistic tasks in patients with Parkinson’s disease
P99 Diffusion imaging and probabilistic tractography of the premotor cortico-subcortical connections in healthy subjects and patients with Parkinson’s disease
P100 Deep brain stimulation and medication in Parkinson’s Disease: Changes in impulse control
P101 Changes of the firing pattern of neurons in the subthalamic nucleus during reach-to-grasp movements in Parkinsonian patients
P102 A long-term study on the safety of rivastigmine capsule and patch in mild to moderate Parkinson’s disease dementia
P103 AFQ056 treatment of levodopa-induced dyskinesias: Results of two randomized controlled trials
P104 Dopamine agonists and demented Parkinson’s disease patients: Really a no go?
P105 Effect of rotigotine on sleep and nocturnal symptoms in Parkinson‘s Disease: Recover study
P106 PROSPERA (PROgressive Supranuclear Palsy and the Effect of Rasagiline)
EUVIMED